Letter from the editor
Dr. Bruce Feinberg provides insight into our latest issue of FOCUS, as we explore the capabilities of real-world evidence and how its application is increasing the value of care in today’s healthcare marketplace.
Real-World Trends in Disease Management
Systemic Lupus Erythematosus (SLE) is an autoimmune disease that triggers inflammation in body tissues. Since SLE is a relatively rare condition adversely affecting the young and productive population, understanding real-world treatment patterns and care gaps is important to guide the development of new treatment options for this debilitating disease.
Real-World Evidence: Why and How
Much has been written in recent years about the advantages and challenges of real-world evidence (RWE) studies, and how best to utilize the data generated, moving forward. To help us better understand the process and to shed some light on RWE studies, Dr. Chadi Nabhan sits down with Dr. Anthony Mato, Associate Attending and CLL Program Director at the Memorial Sloan Kettering Cancer Center in New York.
Use of RWE in Making Therapy Decisions
Providers are recognizing that real-world data and real-world evidence are rapidly entering their clinical practice workflows and starting to affect compensation. Our research explores how RWD and RWE are understood by oncology providers and their perceptions of its utility.